Table 2 Clinical outcomes by AKI status.
No AKI (N = 177) | Any AKI (N = 39) | P valuea | Stage 2/3 AKI (N = 27) | P valueb | |
|---|---|---|---|---|---|
Bronchopulmonary dysplasia | |||||
Grade 1 | 124 (70) | 14 (36) | <0.001 | 8 (30) | <0.001 |
Grade 2 | 40 (23) | 8 (21) | 6 (22) | ||
Grade 3 | 13 (7) | 17 (44) | 13 (48) | ||
Patent ductus arteriosus | 53 (30) | 11 (28) | 0.83 | 8 (30) | 1.00 |
Moderate to large PDA | 41 (23) | 10 (26) | 0.74 | 7 (26) | 0.76 |
Pharmacologic treatment of PDA | 48 (27) | 13 (33) | 0.44 | 10 (37) | 0.28 |
Grade 3-4 intracranial hemorrhage | 21 (12) | 2 (5) | 0.22 | 0 (0) | 0.06 |
Early onset sepsis | 2 (1) | 2 (5) | 0.09 | 1 (4) | 0.45 |
Late onset sepsis | 28 (16) | 11 (28) | 0.07 | 9 (33) | 0.03 |
Severe retinopathy of prematurity | 36 (20) | 7 (18) | 0.74 | 5 (19) | 0.85 |
Necrotizing enterocolitis stage ≥ 2 | 17 (10) | 8 (21) | 0.05 | 8 (30) | 0.002 |
Pulmonary hypertension | 60 (34) | 22 (56) | 0.009 | 15 (56) | 0.04 |
Death | 11 (6) | 14 (36) | <0.001 | 13 (48) | <0.001 |
